---
company: Roadzen Inc.
ticker: RDZN
form: 8-K
filed: 2026-07-06
accession: 0001493152-26-032180
source: https://www.sec.gov/Archives/edgar/data/1868640/000149315226032180/
---

# Roadzen (RDZN) earnings release, July 6, 2026

Roadzen Inc. (RDZN) · Form 8-K, Item 2.02 · Filed 2026-07-06 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1868640/000149315226032180/)

Exhibit

99.1

Roadzen

Delivers Best Quarter in Company History with Q4 FY2026 Revenue of $16.1 Million, Up 42% Year-Over-Year; Record Full-Year Revenue of

$55.0 Million, Up 24%

Roadzen

Posts First ‘Rule of 40’ Quarter in Two Years; FY2026 Net Loss Narrows 69% and Adjusted EBITDA Loss Improves 58%, with Seventh

Straight Quarter of Adjusted EBITDA Gains Nearing Breakeven

Roadzen delivered record fourth-quarter revenue of $16.1 million, up 42% year-over-year and 12% sequentially — the highest quarterly revenue in Company history. Full-year FY2026 revenue rose to a record $55.0 million, up 24% from $44.3 million in FY2025, reflecting sustained multi-quarter acceleration driven by rising customer adoption and expanding enterprise penetration.

Net loss attributable to ordinary shareholders for FY2026 fell approximately 69% to $(22.5) million, or $(0.29) per share, from $(72.9) million, or $(1.04) per share, in FY2025, and full-year operating loss improved 77% to $(14.0) million from $(60.8) million in FY2025. Adjusted

EBITDA loss for the fourth quarter was $(0.4) million, compared to $(1.6) million in the prior-year quarter, and full-year Adjusted EBITDA loss improved to $(3.5) million from $(8.4) million in FY2025 — Roadzen’s seventh consecutive quarter of improvement.

Roadzen’s

AI platform processes over 3 million insurance claims annually and leverages over 4 billion miles of proprietary real-world driving data to power precision underwriting, claims automation, telematics, and driver intelligence. The platform delivers up to 72% accident reduction for fleets. Roadzen’s MGA operations run at an average 85% combined ratio — compared to an industry average of approximately

103% — and claims-to-repair cycle times are cut from an average of ~6 weeks to 48 hours for standard repairs, strengthened by VehicleCare.

Roadzen exited FY2026 at an approximately $64 million annualized revenue run-rate. With over $30 million in new annual revenue commitments already secured in Q1 FY2027 — across insurance contracts, OEM partnerships, fleet deployments, and carrier capacity programs — the

Company has clear visibility towards reaching a $100 million annualized revenue run-rate and positive Adjusted EBITDA for the coming fiscal year.

NEW

YORK, June 29, 2026 (GLOBE NEWSWIRE) – Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the Fiscal 2026 fourth quarter and full year ended March 31, 2026.

Commenting on the Company’s results, Rohan Malhotra, Founder and CEO of Roadzen, stated, “This was the best quarter in our history.

We have been building towards this growth for two years by laying the groundwork — we are seeing increased adoption of our platform, largely driven by the U.S. and India, and democratic growth across all of our product lines. More customers are adopting more of our platform, across more geographies, and at increasing speed.¹

Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.

We are showcasing real-world AI at scale. Unlike general intelligence models, which are large, expensive and general-purpose, our focus is on building specialized models that deliver enterprise intelligence within context — that are built for precision and the lowest cost of delivery, so that our accuracy translates directly into real economic impact for our customers. As adoption grows, the network effects across our data, distribution, and decisioning compound.

Our goal for this year is clear: to be one of a handful of AI companies, globally, with over $100 million in annual recurring revenue with adjusted EBITDA profitability, and growing more than 40-50% a year. We are still early, but the direction is clear, and we have entered

Fiscal 2027 with more momentum, more visibility, and greater conviction than ever before.”

Roadzen’s

CFO, Jean-Noël Gallardo, commented, “The Fiscal fourth quarter represented a clear acceleration in Roadzen’s financial trajectory, with record quarterly revenue growing 42% year-over-year and 12% sequentially, driving meaningful operating leverage and continued improvement in our financial metrics. While our net loss for the quarter was $(7.3) million, or $(0.09) per share, we reduced our full-year Fiscal 2026 net loss by approximately 69% over the prior year. Our Adjusted EBITDA loss narrowed to $(0.4) million — our seventh consecutive quarter of improvement — bringing the Company closer to Adjusted EBITDA breakeven. We are also exceptionally pleased to report our first ‘Rule of 40’ quarter since the U.K. pause. The growth we are seeing in our acquired businesses is being driven by the synergies we have created across the Roadzen platform — by connecting them to our AI, our distribution, and our customer base, we are accelerating their growth well beyond what they could achieve independently.

There is clear momentum in the operating performance of the business, where year-over-year revenue growth has accelerated from an average of

18% in the first half of this year to more than 30% growth in the second half, while our Adjusted EBITDA margin narrowed from -10.2% to -3.3% over the same period — showing both sustained commercial acceleration and a clear trend toward breakeven.

We also made decisive improvements to our balance sheet. We reduced short-term borrowings by approximately 60%, from $19.9 million to $7.8 million, while extending into longer-duration debt — including the extension of our $11.5 million senior secured facility with

Mizuho to July 2027 — strengthening our near-term liquidity position and capital flexibility. We raised capital almost entirely... (truncated) India subsidiary level. The balance sheet clean-up remains a focus for us as we continue to strengthen the foundations of the business.”

Fourth

Quarter and Full Year Financial Highlights

P&L

Revenue and Key Performance Indicators:

Net

Results:

Balance

Sheet

Assets:

Liabilities:

Capitalization: drivebuddyAI

Developments:

Acquisitions:

Strategic Acquisitions Unlock New Markets and Full-Stack Control

On

December 3, 2025, Roadzen acquired majority control of EliteCover, a U.S.-based licensed commercial auto insurance broker and Managing

General Underwriter operating in California, Texas, Illinois, and New Jersey, with Lloyd’s of London Coverholder status. The acquisition provides Roadzen with a regulated underwriting and distribution platform to participate directly in the approximately $80 billion U.S. commercial auto insurance market. Combined with Roadzen’s AI-powered underwriting, telematics-driven risk management, automated claims, and integrated roadside assistance through National Automobile Club, EliteCover enables an end-to-end commercial auto insurance offering on a commission- and fee-based model. The synergies created by integrating EliteCover into the Roadzen platform are expected to drive its growth across the U.S. commercial auto market.

On

January 6, 2026, Roadzen agreed to acquire VehicleCare, an AI-powered vehicle repair and workshop aggregation platform. VehicleCare’s software-enabled network of more than 1,200 workshops across India allows Roadzen to directly manage repair timelines, quality and cost outcomes, delivering over 30% loss-cost reductions versus OEM garages while improving cycle times, transparency, and fraud control. The transaction valued Roadzen’s India subsidiary at approximately $277 million, implying a value of roughly $3.50 per Roadzen share, based on Roadzen’s ownership of approximately 92% of the India subsidiary. Since closing, Roadzen has brought new business to VehicleCare by connecting it to the Company’s AI, insurer relationships, and claims funnel — winning two major insurer mandates that are expected to generate more than $20 million in combined annual revenue, and entering into a strategic partnership with TEMOT International, one of the world’s largest automotive parts distribution networks, strengthening the infrastructure supporting Roadzen’s newly launched 48-hour claims repair turnaround program.

FY2027 – Off to a Strong Start with Over $30 Million in New Annual Revenue Mandates

Financial

Developments

Revenue

& Commercial Deployments:

Strategic

Partnerships & Ecosystem Expansion:

Other

Interest:

For more information about Roadzen Inc., please visit https://roadzen.ai.

About

Roadzen Inc.

Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences. Thousands of clients across North America, Europe, and Asia — from the world’s leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen’s technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes,

Fortune, and Financial Express as one of the world’s top AI innovators. Headquartered in Burlingame, California, Roadzen employs more than 450 people across offices in the U.S., U.K., India, and China. Learn more at www.roadzen.ai.

Cautionary

Statement Regarding Forward Looking Statements

This press release includes forward-looking statements within the meaning of Section

27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,”

“expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, our expected revenue growth and anticipated Adjusted EBITDA breakeven timing, expected revenue and results from announced contracts and strategic partnerships, the anticipated synergies and growth from our acquisitions, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the annual report on Form

10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to... (truncated)ements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact: Investor Contacts: IR@roadzen.ai Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai

Financial

Statements Follow

Roadzen

Inc.

Consolidated

Balance Sheets

(in

US $, except share count)

The accompanying notes are an integral part of these consolidated financial statements.

Roadzen

Inc.

Consolidated

Statements of Operations

(in

US $, except share count)

The accompanying notes are an integral part of these consolidated financial statements.

Roadzen

Inc.

Unaudited

Condensed Consolidated Statements of Cash Flow

(in

US $, except share count)

The accompanying notes are an integral part of these consolidated financial statements.

Non-GAAP

Financial Measures

This press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (Adjusted EBITDA), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flow provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.

Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.

The following tables reconcile our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:

(1)

Fair value changes in financial instruments are considered to be financing costs as they relate to convertible notes and the Forward

Purchase Agreement. These changes are non-cash as these changes in fair value are affected by the volatility of the Company’s share price.

## Financial statements

### Income Statement (Particulars — (in US $, except share count))

| | For the three months ended March 31, – 2026 | For the three months ended March 31, – 2025 | For the year ended March 31, – 2026 | For the year ended March 31, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | 16,121,304 | 11,330,827 | 55,021,792 | 44,296,098 |
| Costs and expenses: | Cost of services | 5,537,522 | 3,893,120 | 21,277,579 | 18,833,218 |
| Costs and expenses: | Research and development | -115,664 | 244,928 | 408,355 | 3,779,955 |
| Costs and expenses: | Sales and marketing | 9,349,677 | 7,133,481 | 29,111,662 | 28,873,150 |
| Costs and expenses: | General and administrative | 6,069,343 | 2,694,733 | 15,976,982 | 51,602,107 |
| Costs and expenses: | Depreciation and amortization | 1,057,462 | 1,046,539 | 2,244,268 | 2,020,610 |
| Costs and expenses: | Total costs and expenses | 21,898,341 | 15,012,801 | 69,018,846 | 105,109,040 |
| Costs and expenses: | Loss from operations | -5,777,037 | -3,681,974 | -13,997,054 | -60,812,942 |
| Costs and expenses: | Interest expense (net) | -1,871,764 | -714,899 | -7,249,803 | -3,247,831 |
| Costs and expenses: | Gain on bargain purchase | 174,248 |  | 174,248 |  |
| Costs and expenses: | Fair value gains/(losses) in financial instruments carried at fair value | 635,187 | 1,681,725 | -3,984,386 | -14,844,420 |
| Costs and expenses: | Impairment of investment | -269,470 | -1,245,326 | -269,470 | -1,245,326 |
| Costs and expenses: | Other income (net) | -193,775 | 3,861,541 | 2,329,515 | 7,073,235 |
| Costs and expenses: | Total other income/(expense) | -1,525,574 | 3,583,041 | -8,999,896 | -12,264,342 |
| Costs and expenses: | Loss before income taxes and equity-method investment activity | -7,302,611 | -98,933 | -22,996,950 | -73,077,284 |
| Costs and expenses: | (Loss)/Income before income tax expense | -7,302,611 | -98,933 | -22,996,950 | -73,077,284 |
| Costs and expenses: | Less: income tax (benefit)/expense | -46,966 | 69,709 | 20,212 | -13,973 |
| Costs and expenses: | Net (loss)/income before non-controlling interest | -7,255,645 | -168,642 | -23,017,162 | -73,063,311 |
| Costs and expenses: | Net loss attributable to non-controlling interest, net of tax | -1,733 | -61,675 | -500,940 | -192,879 |
| Costs and expenses: | Net Loss attributable to Ordinary shareholders | -7,253,912 | -106,967 | -22,516,222 | -72,870,432 |
| Net loss per share attributable to Ordinary shareholders | Basic and diluted | -0.09 | 0 | -0.29 | -1.04 |
| Net loss per share attributable to Ordinary shareholders | Weighted-average number of shares used in computing net loss per share | 79,673,597 | 68,882,560 | 77,454,509 | 69,867,792 |

### Balance Sheet (Particulars — (in US $, except share count))

| | As of March 31, 2026 | As of March 31, 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 6,578,594 | 4,836,576 |
| Current assets: | Accounts receivable, net | 7,500,439 | 2,625,385 |
| Current assets: | Inventories | 116,555 | 202,535 |
| Current assets: | Prepayments and other current assets | 17,833,119 | 19,092,595 |
| Current assets: | Investments | 229,994 | 197,805 |
| Current assets: | Total current assets | 32,258,701 | 26,954,896 |
| Non current assets | Restricted cash | 222,026 | 217,064 |
| Non current assets | Non marketable securities |  | 269,470 |
| Non current assets | Property and equipment, net | 536,997 | 602,923 |
| Non current assets | Goodwill | 7,616,973 | 2,061,553 |
| Non current assets | Operating lease right-of-use assets | 1,374,147 | 1,109,219 |
| Non current assets | Intangible assets, net | 9,651,915 | 1,243,253 |
| Non current assets | Other long-term assets | 997,802 | 120,972 |
| Non current assets | Total Non current assets | 20,399,860 | 5,624,454 |
| Non current assets | Total assets | 52,658,561 | 32,579,350 |
| Current liabilities | Current portion of long-term borrowings | 9,829,713 | 2,904,444 |
| Current liabilities | Short-term borrowings | 7,843,267 | 19,865,645 |
| Current liabilities | Accounts payable and accrued expenses | 30,245,947 | 30,254,010 |
| Current liabilities | Derivative warrant liabilities | 1,987,003 | 1,489,818 |
| Current liabilities | Short-term operating lease liabilities | 325,255 | 318,921 |
| Current liabilities | Other current liabilities | 8,072,789 | 2,102,466 |
| Current liabilities | Total current liabilities | 58,303,974 | 56,935,304 |
| Non current liabilities | Long-term borrowings | 15,612,108 | 139,775 |
| Non current liabilities | Long-term operating lease liabilities | 699,817 | 628,400 |
| Non current liabilities | Other long-term liabilities | 4,561,246 | 566,651 |
| Non current liabilities | Total Non current liabilities | 20,873,171 | 1,334,826 |
| Non current liabilities | Total liabilities | 79,177,145 | 58,270,130 |
| Shareholders’ Equity/(Deficit) | Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of March 31, 2026 and March 31, 2025; 79,695,672 and 74,290,986 shares outstanding as of March 31, 2026 and March 31, 2025 respectively | 112,128,293 | 95,501,291 |
| Shareholders’ Equity/(Deficit) | Accumulated deficit | -246,224,660 | -223,826,442 |
| Shareholders’ Equity/(Deficit) | Accumulated other comprehensive income/(loss) | -1,299,868 | -468,859 |
| Shareholders’ Equity/(Deficit) | Other components of equity | 105,747,998 | 103,720,113 |
| Shareholders’ Equity/(Deficit) | Total shareholders’ deficit | -29,648,237 | -25,073,897 |
| Shareholders’ Equity/(Deficit) | Non-controlling interest | 3,129,653 | -616,883 |
| Shareholders’ Equity/(Deficit) | Total deficit | -26,518,584 | -25,690,780 |
| Shareholders’ Equity/(Deficit) | Total liabilities and Total Deficit | 52,658,561 | 32,579,350 |

### Cash Flow (For the year ended March 31, — (in US $, except share count))

| | For the year ended March 31, – 2026 | For the year ended March 31, – 2025 |
|---|---:|---:|
| Cash flows from operating activities | Net Loss attributable to Ordinary shareholders | -22,516,222 | -72,870,432 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Depreciation and amortization | 2,244,268 | 2,020,610 |
